Inventaire - your friends and communities are your best library - Inventaire

Cites articles 39

Date

Title

Authors

2012-07-25

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset

Andrea Novelletto, Jeanne C Latourelle, Alba Di Pardo, Marie-Helene Saint-Hilaire, Isabel Alonso, Ferdinando Squitieri, Jorge Sequeiros, Carmen Ayuso, Richard H Myers, Michael R. Hayden, James F. Gusella, Tammy Gillis, Christopher A Ross, Steven M Hersch, Russell Margolis, Tetsuo Ashizawa, Jayalakshmi Srinidhi Mysore, Eliana Marisa Ramos, Estrella Gómez-Tortosa, Oksana Suchowersky, Marina Frontali, Diane Lucente, Madaline B Harrison, Andrea Zanko, Karen S. Marder, Marcy E. MacDonald
2012-02-08

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

Andrea Novelletto, Michael R. Hayden, Ferdinando Squitieri, Carmen Ayuso, Marie-Helene Saint-Hilaire, Jorge Sequeiros, Jane S. Paulsen, Bernhard Landwehrmeyer, Richard H Myers
2011-10-04

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

Sarah J. Tabrizi, Carsten Saft, David Craufurd, Raymund A. C. Roos, Bernhard Landwehrmeyer
2011-08

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

Albert Tenesa, Denise M. Kay, Muthukrishnan Eaaswarkhanth, Honglei Chen, Cyrus P Zabetian, Yikyung Park, Jeffery M. Vance, Beate Ritz, Yvette Bordelon, John G Nutt, Stewart A Factor, Kenneth Kendler, John W. Roberts, Taye H Hamza, Erin M Hill-Burns, Shannon L Rhodes, Jennifer S. Montimurro, Victoria I Kusel, Dora Yearout, Ali Samii, Pinky Agarwal, Haydeh Payami
2009-11-10

Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder

Stephen Faraone, Eric Mick, Joseph Biederman, Jordan W Smoller
2009-08-21

Huntington's disease: the case for genetic modifiers

James F. Gusella, Marcy E. MacDonald
2008-08-01

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study

Christopher F McNicoll, Richard H. Roxburgh, Jeanne C Latourelle, Anita L DeStefano, Stefano Goldwurm, Richard H Myers, David Burn, Irene Litvan, Christine Klein, Gianni Pezzoli, Joel S Perlmutter, Marcy E. MacDonald, Mark F. Lew, Oksana Suchowersky, Lawrence I. Golbe, M H Mark, John Growdon, G F Wooten, R L Watts, Mark Guttman, Brad A Racette, Anwar Ahmed, Holly Shill, C. Colin Singer, Marie-Helene Saint-Hilaire, Tiffany Massood, Karen W. Huskey, Tammy Gillis, Jayalakshmi Srinidhi Mysore, Kenneth B. Baker, Ilia Itin, Garth Nicholson, Alastair J. Corbett, Martha A. Nance, Edward Drasby, Stuart Isaacson, Patrick F. Chinnery, Peter P. Pramstaller, Jomana Al-hinti, Anette T. Moller, Karen Ostergaard, Scott J Sherman, Barry Snow, John T. Slevin, Franca Cambi, James F. Gusella
2008-12-17

Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3

Frank Baas, Michael W Tanck, Wim van den Brink
2007-07-01

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease
2007-06-14

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner

Joerg T. Epplen, Carsten Saft
2006-12-22

N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

Lynn A Raymond
2006-10-03

Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds

Stacey S. Cherny, J. Michael Andresen
2006-11-01

Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease

Esther Perez-Navarro, Josep M. Canals
2006-02-14

Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond

Daniel R. Weinberger, Elizabeth M. Tunbridge
2005-11-01

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease

Scott Chandler
2005-05-01

Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
2004-03-17

Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16

Michael R. Hayden, L. Adrienne Cupples, Richard H Myers, Ryan R Brinkman, Andrea Novelletto, Jane S. Paulsen, Qiong Yang, James F. Gusella, Christopher A Ross, Marcy E. MacDonald, Alexandra Durr, Luc Djoussé, Beth Knowlton, Elisabeth W Almqvist, Adam E Rosenblatt, Marina Frontali, Estrella Gómez-Tortosa, David Mayo Cabrero, Andrea Zanko, Ruth K Abramson, Oksana Suchowersky, Madaline B Harrison, Jayalakshmi Srinidhi Mysore
2004-03-01

Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset

Stacey S. Cherny, J. Michael Andresen, Jane S. Paulsen, Bernhard Landwehrmeyer, James F. Gusella, Marcy E. MacDonald, Steven M Hersch, Ira Shoulson, Jack B Penney, Karen S. Marder, Carol Moskowitz, Juan Sanchez-Ramos, Andrew Feigin, Leon Dure, Penelope Hogarth, Nancy S Wexler, Javier Gayán, Denise Brocklebank, David E Housman, Denise Krch
2004-01-01

Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation
2004-03-01

Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.

Michael R. Hayden, Lynn A Raymond, Blair R Leavitt, Cheryl L Wellington, Melinda M Zeron, Jacqueline Shehadeh
2004-11-17

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease

Joerg T. Epplen, Carsten Saft
2003-01-01

The human dopamine D4 receptor repeat sequences modulate expression
2003-01-01

Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
2002-03-01

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

Oskar Hansson, Michael R. Hayden, Sam Brundin, Blair R Leavitt, Lynn A Raymond, Cheryl L Wellington, Melinda M Zeron
2001-06-05

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

Daniel R. Weinberger
2001-11-01

NMDA receptor function in mouse models of Huntington disease

Michael R. Hayden
1999-12-01

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
1999-05-01

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

Erik G Jönsson, Markus M Nöthen
1998-05-01

Huntington disease.
1998-05-01

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

Juha O. Rinne
1997-04-01

The genetic defect causing Huntington's disease: repeated in other contexts?

James F. Gusella
1997-12-01

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele

Christopher Morris

Article - wd:Q30416270

Welcome to Inventaire

the library of your friends and communities

you are offline